Tuberculosis trials and consortium services

Active Definitive Contract Awarded Last action

Contract number
75D30121C10166
Awardee
Awarding agency
Obligated
$2,161,029

Award facts

Opportunity
Contract value 56% obligated
  • $2,251,384.28 Current, with exercised options
  • $3,870,580.28 Potential, with all options
Completion date 58% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 22 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Denver, CO 80204, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00010 · EO 14398 $0
Exercise an Option P00008 $379,142
Exercise an Option P00007 $369,468
Other Administrative Action P00006 -$19,895
Supplemental Agreement for work within scope P00005 $405,000
Exercise an Option P00004 $350,967
Supplemental Agreement for work within scope P00003 $0
Exercise an Option P00002 $342,116
Supplemental Agreement for work within scope P00001 $0
Original award $334,231

About this award

Written by GovTribe AI ·

The Centers for Disease Control and Prevention (CDC Pittsburgh) awarded a definitive contract to Denver Health And Hospital Authority for tuberculosis trials and consortium services on January 1, 2021, with a ceiling value of $3.87 million and ultimate completion date of December 31, 2030.

The originating pre-solicitation, posted February 5, 2020, sought clinical research support services for tuberculosis trials and studies over ten years, including participation in clinical research studies, adherence to study start-up procedures, and involvement in the Tuberculosis Trials Consortium as a member site. The government estimated initiating up to four new studies between the base year and ninth option year, with individual phases supporting zero to two new studies and continuing enrollment, treatment, testing, and follow-up for multiple tuberculosis protocols. Place of performance is Denver, Colorado.

The contract carries no set-aside. Pricing is cost with no fee.

Service Contract Inventory data reflects the contract's actual government-invoiced labor across reported fiscal years: FY2021 recorded 1.3 FTEs and 2,664 contractor hours; FY2022 invoiced $450 thousand across 1.4 FTEs and 2,983 contractor hours at a derived rate of $150.82 per hour; FY2024 invoiced $749 thousand across 1.8 FTEs and 3,631 contractor hours at a derived rate of $206.16 per hour. Denver Health self-performed all reported hours with no subcontractors reported through FY2024.

Vanderbilt University Medical Center serves as a subcontractor, providing Tuberculosis Trials Consortium clinical research services for protocol chair and sub-chair roles as of March 19, 2025.

Subawards

Subcontractor Amount Awarded
Vanderbilt University Medical Center TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES Tuberculosis Trials Consortium (TBTC) Clinical Research Services - services for protocol chair/sub-chair $141,852

Quick answers

Who was awarded contract 75D30121C10166?

75D30121C10166 was awarded to Denver Health And Hospital Authority by CDC Pittsburgh (Centers for Disease Control and Prevention) on January 1, 2021.

How much is contract 75D30121C10166 worth?

The government has obligated $2,161,029 on 75D30121C10166. Its current value, with exercised options, is $2,251,384. Its potential value, with all options, is $3,870,580.

Was contract 75D30121C10166 competed?

The extent of competition for 75D30121C10166 was full and open competition. The government received 22 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login